202
Views
39
CrossRef citations to date
0
Altmetric
Research Article

Targeting of Lipid-Protamine-DNA (LPD) Lipopolyplexes Using RGD Motifs

, Ph.D., , B.Sc., , B.Sc., , Ph.D., , Ph.D., M.Sc., , Ph.D. & , Ph.D. show all
Pages 231-247 | Published online: 24 Nov 2003

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Zhe Wang, Wai-Keung Chui & Paul C Ho. (2010) Integrin targeted drug and gene delivery. Expert Opinion on Drug Delivery 7:2, pages 159-171.
Read now
Qing-Hui Zhou, Ye-Zi You, Chao Wu, Yi Huang & David Oupický. (2009) Cyclic RGD-targeting of reversibly stabilized DNA nanoparticles enhances cell uptake and transfection in vitro. Journal of Drug Targeting 17:5, pages 364-373.
Read now
M. R. Mozafari, C. J. Reed, C. Rostron & V. Hasirci. (2005) A Review of Scanning Probe Microscopy Investigations of Liposome-DNA Complexes. Journal of Liposome Research 15:1-2, pages 93-107.
Read now

Articles from other publishers (35)

Olga A. Sukocheva, Junqi Liu, Margarita E. Neganova, Narasimha M. Beeraka, Yulia R. Aleksandrova, Prasath Manogaran, Ekaterina M. Grigorevskikh, Vladimir N. Chubarev & Ruitai Fan. (2022) Perspectives of using microRNA-loaded nanocarriers for epigenetic reprogramming of drug resistant colorectal cancers. Seminars in Cancer Biology 86, pages 358-375.
Crossref
Hassan Zarei, Bizhan Malaekeh-Nikouei, Mohammad Ramezani & Fatemeh Soltani. (2021) Multifunctional peptides based on low molecular weight protamine (LMWP) in the structure of polyplexes and lipopolyplexes: Design, preparation and gene delivery characterization. Journal of Drug Delivery Science and Technology 62, pages 102422.
Crossref
Shuai Zhen & Xu Li. (2019) Liposomal delivery of CRISPR/Cas9. Cancer Gene Therapy 27:7-8, pages 515-527.
Crossref
Dinglin Zhang & Jianxiang Zhang. (2020) Surface engineering of nanomaterials with phospholipid-polyethylene glycol-derived functional conjugates for molecular imaging and targeted therapy. Biomaterials 230, pages 119646.
Crossref
Waleed Mohammed-Saeid, Jackson Chitanda, Mays Al-Dulaymi, Ronald Verrall & Ildiko Badea. (2017) Design and Evaluation of RGD-Modified Gemini Surfactant-Based Lipoplexes for Targeted Gene Therapy in Melanoma Model. Pharmaceutical Research 34:9, pages 1886-1896.
Crossref
Torben Gjetting, Rasmus Irming Jølck & Thomas Lars Andresen. (2014) Effective Nanoparticle‐based Gene Delivery by a Protease Triggered Charge Switch. Advanced Healthcare Materials 3:7, pages 1107-1118.
Crossref
Rachel M. Levine, Timothy R. Pearce, Maroof Adil & Efrosini Kokkoli. (2013) Preparation and Characterization of Liposome-Encapsulated Plasmid DNA for Gene Delivery. Langmuir 29:29, pages 9208-9215.
Crossref
Surendra Nimesh. 2013. Gene Therapy. Gene Therapy 237 258 .
Rachel M. Levine, Carolyn M. Scott & Efrosini Kokkoli. (2013) Peptide functionalized nanoparticles for nonviral gene delivery. Soft Matter 9:4, pages 985-1004.
Crossref
J Park, K Singha, S Son, J Kim, R Namgung, C-O Yun & W J Kim. (2012) A review of RGD-functionalized nonviral gene delivery vectors for cancer therapy. Cancer Gene Therapy 19:11, pages 741-748.
Crossref
Long Xu, Jamie Betker, Hao Yin & Thomas J. Anchordoquy. (2012) Ligands located within a cholesterol domain enhance gene delivery to the target tissue. Journal of Controlled Release 160:1, pages 57-63.
Crossref
Fatema Tuj Zohra, Yoshie Maitani & Toshihiro Akaike. (2012) mRNA Delivery through Fibronectin Associated Liposome-Apatite Particles: A New Approach for Enhanced mRNA Transfection to Mammalian Cell. Biological and Pharmaceutical Bulletin 35:1, pages 111-115.
Crossref
Aliasger K. Salem & Mark A. Behlke. 2011. RNA Interference. RNA Interference 174 215 .
Jigar Lalani & Ambikanandan Misra. 2011. Challenges in Delivery of Therapeutic Genomics and Proteomics. Challenges in Delivery of Therapeutic Genomics and Proteomics 127 206 .
Long Xu & Thomas Anchordoquy. (2011) CLINICAL TRIALS AND TRANSLATIONAL MEDICINE COMMENTARY: Drug Delivery Trends in Clinical Trials and Translational Medicine: Challenges and Opportunities in the Delivery of Nucleic Acid-Based Therapeutics. Journal of Pharmaceutical Sciences 100:1, pages 38-52.
Crossref
Long Xu & Thomas J. Anchordoquy. (2010) Effect of Cholesterol Nanodomains on the Targeting of Lipid-Based Gene Delivery in Cultured Cells. Molecular Pharmaceutics 7:4, pages 1311-1317.
Crossref
Ales Prokop & Jeffrey M. Davidson. (2008) Nanovehicular Intracellular Delivery Systems. Journal of Pharmaceutical Sciences 97:9, pages 3518-3590.
Crossref
Dinesh B. Shenoy & Mansoor M. Amiji. (2007) An Overview of Condensing and Noncondensing Polymeric Systems for Gene Delivery. Cold Spring Harbor Protocols 2007:5, pages pdb.top9.
Crossref
Xiao-Bing Xiong, Abdullah Mahmud, Hasan Uludaǧ & Afsaneh Lavasanifar. (2007) Conjugation of Arginine-Glycine-Aspartic Acid Peptides to Poly(ethylene oxide)- b -poly(ε-caprolactone) Micelles for Enhanced Intracellular Drug Delivery to Metastatic Tumor Cells . Biomacromolecules 8:3, pages 874-884.
Crossref
Weijun Li & Francis C. SzokaJr.Jr.. (2007) Lipid-based Nanoparticles for Nucleic Acid Delivery. Pharmaceutical Research 24:3, pages 438-449.
Crossref
Yoshiyuki Hattori & and Yoshie Maitani. (2007) DNA/Lipid Complex Incorporated with Fibronectin to Cell Adhesion Enhances Transfection Efficiency in Prostate Cancer Cells and Xenografts. Biological and Pharmaceutical Bulletin 30:3, pages 603-607.
Crossref
Prokop Ales & Davidson Jeffrey M.. 2007. Principles of Tissue Engineering. Principles of Tissue Engineering 493 515 .
P Dubey, S Vyas & S Mahor. 2006. Nanotechnology for Cancer Therapy. Nanotechnology for Cancer Therapy 643 661 .
Jung Soo Suk, Junghae Suh, Kokleong Choy, Samuel K. Lai, Jie Fu & Justin Hanes. (2006) Gene delivery to differentiated neurotypic cells with RGD and HIV Tat peptide functionalized polymeric nanoparticles. Biomaterials 27:29, pages 5143-5150.
Crossref
Alison L. Dunehoo, Meagan Anderson, Sumit Majumdar, Naoki Kobayashi, Cory Berkland & Teruna J. Siahaan. (2006) Cell Adhesion Molecules for Targeted Drug Delivery. Journal of Pharmaceutical Sciences 95:9, pages 1856-1872.
Crossref
Lali Medina-Kauwe. 2006. Gene Therapy for Neurological Disorders. Gene Therapy for Neurological Disorders 115 140 .
An Cao, Dominique Briane & Robert Coudert. 2006. 135 190 .
L K Medina-Kauwe, J Xie & S Hamm-Alvarez. (2005) Intracellular trafficking of nonviral vectors. Gene Therapy 12:24, pages 1734-1751.
Crossref
Kai Temming, Raymond M. Schiffelers, Grietje Molema & Robbert J. Kok. (2005) RGD-based strategies for selective delivery of therapeutics and imaging agents to the tumour vasculature. Drug Resistance Updates 8:6, pages 381-402.
Crossref
Zhouen Zhang, Hiroshi Harada, Kazuhito Tanabe, Hiroshi Hatta, Masahiro Hiraoka & Sei-ichi Nishimoto. (2005) Aminopeptidase N/CD13 targeting fluorescent probes: Synthesis and application to tumor cell imaging. Peptides 26:11, pages 2182-2187.
Crossref
Xiao-Bing Xiong, Yue Huang, Wan-liang Lu, Xuan Zhang, Hua Zhang, Tsuneji Nagai & Qiang Zhang. (2005) Enhanced intracellular delivery and improved antitumor efficacy of doxorubicin by sterically stabilized liposomes modified with a synthetic RGD mimetic. Journal of Controlled Release 107:2, pages 262-275.
Crossref
Martin C. Woodle & Patrick Y. Lu. (2005) Nanoparticles deliver RNAi therapy. Materials Today 8:8, pages 34-41.
Crossref
Xiao-Bing Xiong, Yue Huang, Wan-Liang LU, Xuan Zhang, Hua Zhang, Tsuneji Nagai & Qiang Zhang. (2005) Intracellular delivery of doxorubicin with RGD-modified sterically stabilized liposomes for an improved antitumor efficacy: In vitro and in vivo. Journal of Pharmaceutical Sciences 94:8, pages 1782-1793.
Crossref
Takuro Niidome & Yoshiki Katayama. 2005. Non-viral Gene Therapy. Non-viral Gene Therapy 87 102 .
P Medberry, S Dennis, T Van Hecke & R.K DeLong. (2004) pDNA bioparticles: comparative heterogeneity, surface, binding, and activity analyses. Biochemical and Biophysical Research Communications 319:2, pages 426-432.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.